|
|
Biomarkers
|
|
Biomarkers
The discovery of protein biomarkers that cause disease or correlate with an increased risk for progression of disease will facilitate the development of new treatments and therapeutics to improve health outcomes.
The utility of the biomarker is not confined to the biomedical arena but can be applied to a wide range of sectors with agricultural and nutraceutical application.
Diabesity
Plasma biomarkers are proteins that exist in the blood which can be measured and used as a diagnostic tool as a predictor of disease.
Diabesity is the term covering the two emerging diseases of modern society, diabetes and obesity.
Recent News: Proteomics International has partnered with the world renowned Busselton Health Study and Fremantle Hospital, Western Australia to find biomarkers for diabesity - Media Release - more
Proteomics International leads a collaborative study to identify protein biomarkers for diabesity. In partnership with the Centre for Food and Genomic Medicine, a Western Australian Centre of Excellence, the company uses a modified version of its Bioven process for discovery of causative biomarkers for diabetes and obesity. A biomarker can then be applied in the development of diagnostic and predictive tools to assess an individuals risk of developing the condition.
|
 |
|
 |